NPEPPS
Basic information
Region (hg38): 17:47522941-47624665
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (15 variants)
- not provided (10 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPEPPS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 15 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 1 | 2 | 3 | |||
non coding ? | 1 | |||||
Total | 0 | 0 | 15 | 4 | 3 |
Variants in NPEPPS
This is a list of pathogenic ClinVar variants found in the NPEPPS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-47531338-G-T | not specified | Uncertain significance (Dec 14, 2023) | ||
17-47531344-T-C | not specified | Uncertain significance (Sep 14, 2022) | ||
17-47531382-G-C | not specified | Likely benign (Apr 07, 2023) | ||
17-47531385-T-C | not specified | Likely benign (Apr 07, 2023) | ||
17-47531409-C-T | not specified | Uncertain significance (Jul 19, 2022) | ||
17-47531418-C-T | Benign (Jul 26, 2018) | |||
17-47531519-C-T | Likely benign (Dec 31, 2019) | |||
17-47531554-A-G | not specified | Uncertain significance (Dec 16, 2023) | ||
17-47545902-C-T | Likely benign (Mar 01, 2023) | |||
17-47582823-A-G | not specified | Uncertain significance (Nov 13, 2023) | ||
17-47585524-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
17-47585666-T-C | not specified | Uncertain significance (Aug 06, 2021) | ||
17-47587239-A-G | Benign (Jun 27, 2018) | |||
17-47587320-A-G | Benign (Jul 13, 2018) | |||
17-47587351-AATATTTTTAAGTGCTCAAAT-A | Likely benign (Dec 30, 2023) | |||
17-47590709-G-C | Benign (Jul 13, 2018) | |||
17-47590838-G-A | not specified | Uncertain significance (Dec 09, 2023) | ||
17-47590876-A-G | not specified | Uncertain significance (Nov 27, 2023) | ||
17-47592050-T-C | not specified | Uncertain significance (Aug 12, 2021) | ||
17-47596446-A-G | not specified | Uncertain significance (Oct 12, 2021) | ||
17-47599679-G-A | not specified | Uncertain significance (Dec 26, 2023) | ||
17-47601671-C-G | not specified | Uncertain significance (Dec 15, 2022) | ||
17-47601712-G-A | not specified | Uncertain significance (Aug 15, 2023) | ||
17-47603942-C-T | not specified | Uncertain significance (Jul 14, 2021) | ||
17-47603954-A-T | not specified | Uncertain significance (Mar 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NPEPPS | protein_coding | protein_coding | ENST00000322157 | 23 | 100335 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 2.89e-8 | 121529 | 0 | 3 | 121532 | 0.0000123 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.98 | 222 | 463 | 0.479 | 0.0000236 | 5944 |
Missense in Polyphen | 35 | 161.24 | 0.21706 | 2125 | ||
Synonymous | 0.893 | 148 | 162 | 0.911 | 0.00000815 | 1733 |
Loss of Function | 6.42 | 0 | 48.0 | 0.00 | 0.00000245 | 623 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000303 | 0.0000303 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000112 | 0.000112 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.000112 | 0.000112 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Aminopeptidase with broad substrate specificity for several peptides. Involved in proteolytic events essential for cell growth and viability. May act as regulator of neuropeptide activity. Plays a role in the antigen-processing pathway for MHC class I molecules. Involved in the N-terminal trimming of cytotoxic T-cell epitope precursors. Digests the poly-Q peptides found in many cellular proteins. Digests tau from normal brain more efficiently than tau from Alzheimer disease brain. {ECO:0000269|PubMed:10978616, ECO:0000269|PubMed:11062501, ECO:0000269|PubMed:17154549, ECO:0000269|PubMed:17318184, ECO:0000269|PubMed:19917696}.;
Recessive Scores
- pRec
- 0.200
Intolerance Scores
- loftool
- 0.374
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 57.31
Haploinsufficiency Scores
- pHI
- 0.206
- hipred
- N
- hipred_score
- 0.380
- ghis
- 0.481
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.795
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Npepps
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein polyubiquitination;proteolysis;peptide catabolic process;cellular response to hypoxia;positive regulation of protein targeting to mitochondrion
- Cellular component
- nucleus;cytoplasm;cytosol;extracellular exosome
- Molecular function
- aminopeptidase activity;zinc ion binding;peptide binding;metalloaminopeptidase activity